Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation-Reference-Cited by-同舟云学术

Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation

Published:2004-05-15 Issue:10 Volume:113 Page:1440-1446
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Dwyer Karen M.,Robson Simon C.,Nandurkar Harshal H.,Campbell Duncan J.,Gock Hilton,Murray-Segal Lisa J.,Fisicaro Nella,Mysore Tharun B.,Kaczmarek Elzbieta,Cowan Peter J.,d’Apice Anthony J.F.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference41 articles.

1. Identification and Characterization of CD39/Vascular ATP Diphosphohydrolase

2. CD39 Modulates Endothelial Cell Activation and Apoptosis

3. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells.

4. Thrombosis and Inflammation as Multicellular Processes: Significance of Cell-Cell Interactions

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of endothelial-targeted CD39 as a therapy for ischemic stroke;Journal of Thrombosis and Haemostasis;2024-08

2. GENE-MODIFIED PIGS AS DONORS FOR LIVER XENOTRANSPLANTATION: HOW MANY MODIFICATIONS ARE NEEDED?;European Journal of Transplantation;2023-09

3. Cardiac Xenotransplantation: a New Frontier for Advanced Heart Failure;Current Treatment Options in Cardiovascular Medicine;2023-02-08

4. The future treatment for type 1 diabetes: Pig islet- or stem cell-derived β cells?;Frontiers in Endocrinology;2023-01-05

5. Advances in Innate Immunity to Overcome Immune Rejection during Xenotransplantation;Cells;2022-11-30